MedPath

A clinical study for evaluating the efficacy of soft drink containing reduced type of indigestible dextrin on the function of intestinal regulation to subjects having tendency toward constipation. -Randomised double-blind placebo-controlled trial

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000021665
Lead Sponsor
KSO Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Individuals taking antiflatulents and/or laxatives(including purgative drugs) in common use (2) Individuals taking health foods in common use, including food for specified health use, which influence intestinal regulation at the point of screening examination (3) Individuals taking antibiotics and/or drugs which influence laxatives(including purgative drugs) in common use at the point of screening examination (4) Individuals daily consuming alcohol as equivalent amount of sake more than 360ml (5) Individuals who are not able to stop consumption of foods containing lactic acid bacteria, bifidobacteria, natto bacteria, oligosaccharides, dietary fibers, high amount of sugar alcohol and/or other health foods including food for specified health use, which influence intestinal regulation during the study period (6) Individuals presenting known food allergy (7) Individuals who are suffered from a disease which needs treatment urgently or individuals with severe complications (8) Individuals with a digestive organ disease or surgical history who has an influence on digestive absorption and defecation (9) Individuals who are judged to be unsuitable as a subject from an answer of a subjective background questionnaire (10) Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period (11) Individuals who are under treatment or have a history of drug/alcohol dependence (12) Individuals who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics (13) Individuals who are judged as unsuitable for the study by the investigator for the other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Defecation frequency per day, Defecation frequency per week, Fecal amount. Time of assessment: after two-week intake of active/placebo drinks, defecation frequency, defecation frequency and fecal amount are assessed on a weekly basis.
Secondary Outcome Measures
NameTimeMethod
Fecal shape, color and odor. Feeling after defecation
© Copyright 2025. All Rights Reserved by MedPath